Fennec Pharmaceuticals (FRX) Stock Chart & Stock Price History C$11.99 +0.48 (+4.17%) As of 07/22/2025 09:30 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesBuy This Stock Fennec Pharmaceuticals Stock Price Performance The Fennec Pharmaceuticals (FRX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 32.93%, with a year-to-date return of 35.17%. In the past month, the stock has increased 11.33%, reflecting recent market activity. As of the latest close, Fennec Pharmaceuticals traded at C$11.99 with a market cap of C$231.22 million and volume of 1,504 shares. Five years ago, the stock traded at C$11.82, representing a 1.44% increase over that period. At the time, it had a market cap of C$299.71 million and a volume of 456 shares. Receive FRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.01%1 Month Performance+11.33%3 Month PerformanceN/AYear-To-Date Performance+35.17%1 Year Performance+32.93%5 Year Performance+1.44% FRX Stock Chart for Wednesday, July, 23, 2025 FRX Chart by TradingView Fennec Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/22/2025C$11.51C$11.99+4.17%C$11.99C$11.991,504 shsC$231.22 million07/21/2025C$11.64C$11.51-1.12%C$11.55C$11.51300 shsC$221.97 million07/18/2025C$11.98C$11.64-2.84%C$11.84C$11.64200 shsC$224.47 million07/17/2025C$11.67C$11.98+2.66%C$11.98C$11.98144 shsC$231.03 million07/16/2025C$11.67C$11.67C$11.67C$11.67100 shsC$225.05 million07/15/2025C$11.92C$11.67-2.10%C$11.67C$11.67100 shsC$225.05 million07/14/2025C$12.10C$11.92-1.49%C$12.05C$11.92202 shsC$229.87 million07/11/2025C$12.50C$12.10-3.20%C$12.99C$12.101,582 shsC$233.35 million07/10/2025C$11.89C$12.50+5.13%C$12.50C$12.121,188 shsC$241.06 million07/09/2025C$11.89C$11.89C$11.89C$11.89200 shsC$229.30 million Get the Latest News and Ratings for FRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 07/08/2025C$11.62C$11.89+2.32%C$11.89C$11.89200 shsC$229.30 million07/07/2025C$12.16C$11.62-4.44%C$11.86C$11.621,243 shsC$224.09 million07/04/2025C$11.89C$12.16+2.27%C$12.16C$12.141,210 shsC$234.50 million07/03/2025C$11.69C$11.89+1.71%C$11.90C$11.69902 shsC$229.30 million07/02/2025C$11.29C$11.69+3.54%C$11.69C$11.64216 shsC$225.44 million07/01/2025C$11.29C$11.29C$11.29C$11.002,711 shsC$217.72 million06/30/2025C$11.29C$11.29C$11.29C$11.002,711 shsC$217.72 million06/27/2025C$11.33C$11.29-0.35%C$11.29C$11.002,711 shsC$217.72 million06/26/2025C$11.81C$11.33-4.06%C$11.34C$11.33200 shsC$218.50 million06/25/2025C$11.56C$11.81+2.16%C$11.81C$11.311,101 shsC$227.75 million06/24/2025C$10.77C$11.56+7.34%C$11.56C$10.992,588 shsC$222.93 million06/23/2025C$10.77C$10.77C$10.77C$10.61200 shsC$207.70 million Related Companies SLS Stock Chart CRON Stock Chart TLRY Stock Chart AIM Stock Chart ITH Stock Chart CRDL Stock Chart GXE Stock Chart GPH Stock Chart EQ Stock Chart MDNA Stock Chart Receive FRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:FRX) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fennec Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fennec Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FRX Stock Alerts